Sleep during opiate withdrawal is notoriously difficult because the same brain systems opioids suppress come roaring back when the drug is removed, flooding your body with stimulating neurochemicals at exactly the hours you need rest. The good news is that several evidence-based strategies, from specific prescription medications to structured behavioral techniques, can meaningfully improve your sleep during this period. None of them is a magic fix, and the first few nights will likely still be rough, but stacking the right approaches makes the difference between lying awake until dawn and getting enough rest to keep moving forward.
Why Withdrawal Makes Sleep So Hard
To understand why your body refuses to sleep during withdrawal, it helps to know what opioids were doing to your brain in the first place. Opioids dampen the activity of a tiny cluster of brain cells called the locus coeruleus, which is one of the body’s primary producers of noradrenaline, the chemical behind your fight-or-flight response. When you stop taking opioids, those neurons don’t just return to normal. They become hyperactive, firing at more than double their usual rate.1PubMed. Local opiate withdrawal in locus coeruleus neurons in vitro That surge of noradrenaline is what drives the sweating, racing heart, anxiety, and jittery restlessness that make sleep feel impossible.
On top of the noradrenaline flood, opioid withdrawal also ramps up the orexin system, a signaling network that promotes wakefulness. Normally, orexin helps you stay alert during the day and quiets down at night. During withdrawal, orexin signaling increases, which simultaneously disrupts sleep, intensifies drug cravings, and makes the body feel like it needs to stay on high alert.2PubMed. Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper So you’re being hit from two directions at once: too much adrenaline-like stimulation and a wakefulness drive that won’t shut off.
What Happens to Your Sleep Pattern
Withdrawal doesn’t just make it harder to fall asleep. It changes the structure of sleep itself. Polysomnography studies of people with opioid dependence show reduced total sleep time, lower sleep efficiency, and longer sleep latency, meaning it takes much longer to actually fall asleep once you lie down.3Journal of Clinical Neurophysiology. Sleep Profile in Opioid Dependence: A Polysomnographic Case–Control Study Limb movements also increase, which contributes to the restless, thrashing sensation many people describe during early withdrawal.
Animal research tracking sleep across the first week of withdrawal offers a rough timeline. In mice taken off morphine, the deepest phase of sleep, the slow-wave sleep your brain needs most for restoration, was measurably reduced during the first two days. Interestingly, total sleep time actually rebounded somewhat by day two, but the quality of that sleep remained poor because the deep-sleep component stayed suppressed.4PubMed Central. Biological sex influences sleep phenotype in mice experiencing spontaneous opioid withdrawal The practical takeaway: even when you start sleeping again after the first couple of days, don’t be surprised if you wake up feeling unrested. Your brain is sleeping lighter than normal, and that takes additional time to normalize.
Prescription Medications That Target Withdrawal Insomnia
If you’re going through withdrawal under medical supervision, or can access a prescriber, several medications address the specific mechanisms keeping you awake. These aren’t general sleeping pills; they work because they target the noradrenaline surge or orexin overdrive that withdrawal creates.
Alpha-2 Agonists for the Adrenaline Surge
Clonidine and lofexidine work by turning down the noradrenaline output that drives so many withdrawal symptoms, including the inability to sleep. Lofexidine is specifically FDA-approved for managing opioid withdrawal symptoms and has been shown to be both effective and safe for that purpose.5PubMed Central. A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms Clonidine, while not FDA-approved for withdrawal specifically, is widely prescribed off-label and does the same thing: it dials down the locus coeruleus hyperactivity that is the root cause of your racing heart, sweating, and anxiety at night. Both medications can lower blood pressure, so your prescriber will usually want to monitor you, especially if you’re also dehydrated from vomiting or diarrhea.
Orexin Receptor Antagonists
Because withdrawal ramps up orexin signaling, drugs that block orexin receptors are a logical fit. Suvorexant, already approved for general insomnia, was studied specifically during a buprenorphine taper and improved both sleep disturbance and withdrawal symptoms compared to placebo.2PubMed. Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper Animal research with another orexin-blocking drug showed that daily treatment during opioid abstinence not only reduced physiological disruption but also decreased drug-seeking behavior afterward.6PubMed Central. Daily treatment with the dual orexin receptor antagonist DORA-12 during oxycodone abstinence decreases oxycodone conditioned reinstatement This class of medication is relatively new to the withdrawal context, but it addresses the problem at its source rather than just sedating you, which is why researchers are excited about it.
Mirtazapine and Trazodone
Mirtazapine, an antidepressant with strong sedating effects at low doses, has gathered attention as a non-addictive sleep aid during opioid withdrawal.7PubMed Central. Mirtazapine: A One-Stop Strategy for Treatment of Opioid Withdrawal Symptoms One reason it works well in this context may be that mirtazapine and trazodone, another sedating antidepressant often prescribed for sleep, appear to involve the opioid system as part of their mechanism of action. Researchers have proposed that this opioid-related profile helps explain why these drugs are effective at inducing and maintaining sleep, especially when traditional sedatives like benzodiazepines are contraindicated.8PubMed. Trazodone and mirtazapine: A possible opioid involvement in their use (at low dose) for sleep? Neither drug carries the addiction risk that makes benzodiazepines problematic during recovery, which is a significant advantage.
Gabapentin for Restlessness and Pain
Gabapentin has a specific niche during withdrawal: it helps with the restless legs, muscle aches, and heightened pain sensitivity that keep people tossing and turning. In one study of patients undergoing rapid opioid detoxification, gabapentin at 1200 mg reduced restlessness scores from a mean of 3.2 to 1.2 on a 0-to-4 scale and also improved pain tolerance, which had dropped sharply after detox.9PubMed. Use of gabapentin for attenuation of symptoms following rapid opiate detoxification (ROD)–correlation with neurophysiological parameters That said, a randomized trial comparing gabapentin, pregabalin, and placebo for overall withdrawal symptom reduction found no significant differences between the three groups, suggesting gabapentin’s benefits may be most noticeable for specific symptoms like restless legs and pain rather than as a broad-spectrum withdrawal treatment.10Addictive Disorders & Their Treatment. Gabapentin, Pregabalin, and Placebo in Reducing Opioid Withdrawal Symptoms in Opioid-dependent Individuals: A Randomized-controlled Trial If restlessness is your primary barrier to sleep, gabapentin is worth discussing with your doctor. If it’s more about anxiety and a wired feeling, an alpha-2 agonist or mirtazapine may be a better fit.
Dealing with Restless Legs
The crawling, aching, irresistible-urge-to-move sensation in your legs during withdrawal isn’t random. Researchers have identified a shared neuronal mechanism linking restless legs syndrome, the restlessness caused by some psychiatric medications, and opioid-withdrawal restlessness. All three appear to involve changes in how the brain’s dopamine and opioid receptor systems interact in specific circuits connecting the striatum and the pallidum.11Sleep. Restless legs syndrome, neuroleptic-induced akathisia, and opioid-withdrawal restlessness: shared neuronal mechanisms? What this means practically is that when chronic opioid use stops, the neurons that were being suppressed become sensitized and overactive, creating a restlessness signal that your legs bear the brunt of.
For managing restless legs during withdrawal specifically, the most actionable options are gabapentin (discussed above), gentle stretching or movement before bed, and warm baths. Hot and cold flashes are common during withdrawal, and warmth can temporarily calm the restlessness. Some people find that a weighted blanket helps, though this is more anecdotal than rigorously tested. The restless legs typically peak during the first three to five days of acute withdrawal and then gradually ease, though they can linger at lower intensity for weeks.
Cognitive Behavioral Therapy for Insomnia
CBT for insomnia, often abbreviated CBT-I, is the gold-standard non-drug treatment for chronic insomnia in the general population, and there’s growing evidence it works during and after opioid withdrawal too. A randomized trial of people on methadone maintenance found that CBT-I produced significantly earlier and greater improvements in sleep quality scores compared to basic psychoeducation, with meaningful sleep improvements appearing by about week five of the program.12PubMed Central. The Effect of Cognitive Behavior Therapy in Insomnia due to Methadone Maintenance Therapy: A Randomized Clinical Trial
Another study embedded group CBT-I into an outpatient substance use disorder clinic and found that insomnia scores dropped below the clinical threshold in 80% of the CBT-I group, compared to 25% of those receiving standard care.13PubMed Central. A comparison of cognitive behavioral therapy for insomnia to standard of care in an outpatient substance use disorder clinic embedded within a therapeutic community The study did note challenges with recruitment and implementation, so those numbers come with some caveats, but the direction is encouraging.
CBT-I involves techniques like sleep restriction (spending less time in bed so you build up stronger sleep drive), stimulus control (only using your bed for sleep, getting up if you’ve been lying awake for 20 minutes), and restructuring the anxious thoughts that spiral when you can’t sleep. During acute withdrawal, the sleep restriction component may feel brutal since you’re already sleep-deprived. Many clinicians ease into it and focus first on stimulus control and cognitive techniques during the worst days, then layer in sleep restriction once the acute phase passes. Apps and online programs can deliver basic CBT-I, though having a therapist familiar with substance use adds value.
What Probably Won’t Help
Two popular alternatives, melatonin and acupuncture, have been specifically tested in this population and failed to show benefits.
A randomized, double-blind, placebo-controlled trial of melatonin for post-acute withdrawal among men in residential treatment found no significant differences between melatonin and placebo on any measured outcome. The researchers concluded that melatonin’s effect on sleep and withdrawal symptoms was no different from placebo in their sample.14Duquesne Scholarship Collection. The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program (M-Paws): A Randomized, Double-Blind, Placebo Controlled Trial This makes sense when you consider that withdrawal insomnia isn’t primarily a circadian rhythm problem. Your brain knows it’s nighttime. The issue is that noradrenaline and orexin are screaming too loudly for the circadian signal to matter much.
Auricular acupuncture, sometimes called the NADA protocol, is widely used in addiction treatment settings. But a randomized controlled trial comparing NADA acupuncture, a different acupuncture point protocol, and a relaxation-only control group found that all three groups improved on insomnia and anxiety measures, with no significant difference between them. Neither acupuncture treatment outperformed the control group at five weeks or three months.15PubMed Central. Auricular acupuncture for substance use: a randomized controlled trial of effects on anxiety, sleep, drug use and use of addiction treatment services The improvement in all groups likely reflects the natural trajectory of recovery rather than any treatment effect. If acupuncture helps you relax, it isn’t doing harm, but don’t count on it as a sleep intervention.
Practical Sleep Strategies That Don’t Require a Prescription
Beyond CBT-I and medications, several practical adjustments address the specific problems withdrawal creates at night.
- Temperature management: Night sweats and chills alternate unpredictably during withdrawal. Layering light, breathable bedding that you can throw off or pull back on is more useful than one heavy comforter. Keep your room cooler than you think you need it; you can always add a layer, but waking up soaked in sweat is harder to recover from.
- Timing your fluids: Dehydration from diarrhea and sweating is common, and you need to replace fluids. But chugging water right before bed guarantees bathroom trips. Front-load your fluid intake earlier in the day and evening, and keep just a small amount by the bed for sipping.
- Movement earlier in the day: Even a walk around the block, if you can manage it, helps burn off some of the excess noradrenaline energy. Avoid vigorous exercise within three or four hours of bedtime, though, since your body is already overstimulated and doesn’t need the additional adrenaline push.
- Limiting screen time: Your brain during withdrawal is already hypersensitive to stimulation. Bright screens in the hour before bed add one more alerting signal on top of everything else. If you’re going to use your phone to distract yourself from discomfort, at least dim the screen and use a warm-light filter.
These adjustments won’t single-handedly override the neurochemistry of withdrawal. But they remove obstacles. When your body finally does settle enough to produce drowsiness, you want nothing else standing in the way.
Why Fixing Sleep Matters for Staying in Recovery
Sleep disruption during withdrawal isn’t just uncomfortable. It’s a genuine risk factor for relapse. Research on insomnia and opioid use disorder recovery found that people with clinical insomnia had roughly four times the odds of returning to use compared to those without insomnia, and that elevated risk persisted at one month, three months, and six months after treatment.16Sleep. Insomnia symptoms are associated with return to use and non-fatal overdose following opioid use disorder treatment A narrative review of the topic put it bluntly: insomnia resurges during detoxification, and unless treated adequately, it can lead to relapse.17PubMed Central. Treatment of insomnia associated with alcohol and opioid use: a narrative review
The connection makes intuitive sense. When you’re exhausted, emotionally depleted, and your defenses are down, the memory of how quickly an opioid could bring relief and sleep becomes overpowering. Treating sleep problems aggressively during and after withdrawal isn’t a luxury or a side concern. It’s a core part of protecting your recovery.
Sleep Problems That Linger on Maintenance Medications
If you’ve transitioned to buprenorphine or methadone maintenance, you might expect your sleep to normalize. It often improves, but roughly 60% of people on buprenorphine for opioid use disorder still report clinically significant insomnia symptoms. Those with worse insomnia also tend to report higher levels of depression, anxiety, and stress, and they’re more likely to say that poor sleep is actively interfering with their treatment.18PLOS ONE. Insomnia symptoms and neurofunctional correlates among adults receiving buprenorphine for opioid use disorder
A study comparing sleep problems in methadone-maintained and buprenorphine-maintained patients found few differences between the two medications on sleep measures. Instead, the strongest predictor of sleep impairment was co-occurring psychiatric dysfunction, things like depression, anxiety, and trauma.19PubMed Central. Frequency and Correlates of Sleep Disturbance in Methadone and Buprenorphine-maintained Patients This means that if your sleep remains poor even after you’ve been stabilized on medication-assisted treatment, the culprit is more likely an untreated mental health condition than the maintenance medication itself. Addressing the anxiety, depression, or PTSD that often co-exists with opioid use disorder may do more for your sleep at that stage than any sleep-specific intervention.
This is also where CBT-I becomes especially valuable. During acute withdrawal, there’s only so much a behavioral approach can accomplish against the neurochemical storm. But once you’re stabilized and the acute phase is over, the insomnia that lingers is often driven by conditioned patterns: lying in bed dreading another sleepless night, checking the clock, catastrophizing about tomorrow. Those are exactly the patterns CBT-I was designed to break, and the evidence from maintenance populations suggests it works well in this context.12PubMed Central. The Effect of Cognitive Behavior Therapy in Insomnia due to Methadone Maintenance Therapy: A Randomized Clinical Trial
Benzodiazepines and Why Doctors Are Cautious
People going through withdrawal sometimes ask about benzodiazepines like diazepam or lorazepam, which are powerful sedatives that would certainly knock you out. Most addiction medicine specialists avoid prescribing them in this context for a straightforward reason: benzodiazepines carry their own addiction risk, and someone in the process of recovering from one substance dependence is especially vulnerable to developing another. The combination of opioids and benzodiazepines also carries a high overdose risk if relapse occurs while the benzodiazepine is still in your system.
The same caution applies to over-the-counter sleep aids like diphenhydramine (the active ingredient in many PM formulas). While not habit-forming in the same way, they tend to produce groggy, low-quality sleep and can worsen the restless legs and dry mouth that withdrawal is already causing. They’re unlikely to do much against the level of neurochemical disruption at play.
This is ultimately why the medications discussed earlier, alpha-2 agonists, orexin antagonists, mirtazapine, and gabapentin, are the preferred tools. They address withdrawal-specific sleep disruption without creating new dependence risks or dangerous drug interactions. If a doctor dismisses your sleep complaints during withdrawal as something you just have to tough out, it’s worth pushing back. Evidence-based options exist, and as the relapse data shows, sleep is not a secondary concern.